7 Publikationen
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2977978P. Goon, O. Sauzet, M. Schuermann, F. Oppel, S. Y. Shao, L. - U. Scholtz, H. Sudhoff, and M. Goerner, “Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy”, npj Vaccines, 2023, 8, : 49.PUB | DOI | WoS | PubMed | Europe PMC
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186S. Shao, L. - U. Scholtz, S. Gendreizig, L. Martínez-Ruiz, J. Florido, G. Escames, M. Schürmann, C. Hain, L. Hose, A. Mentz, et al., “Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes”, BMC Cancer, 2023, 23, : 47.PUB | PDF | DOI | WoS | PubMed | Europe PMC
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718F. Oppel, S. Shao, S. Gendreizig, P. Kühnel, V. Przybycin, C. Hain, P. Schmidt, M. Schürmann, P. Goon, K. Niehaus, et al., in Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA, American Association For Cancer Research (Aacr), 2022, p. 111-111.PUB | DOI | WoS
-
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2967816S. Gendreizig, J. M. Neumann, L. Loganathan, L. Hose, P. Goon, F. Oppel, F. Brasch, K. Niehaus, and H. Sudhoff, “P35 Spatial proteomics and metabolomics investigations in head & neck cancers”, Oral Oncology, 2022, 134, : 106164.PUB | DOI | WoS
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817F. Oppel, S. Gendreizig, P. Kühnel, L. Martínez-Ruiz, S. Shao, P. Schmidt, C. Hain, M. Schürmann, L. Hose, H. Pabla, et al., in Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management (Ed.: Amsterdam University Medical Centers), Elsevier , 2022.PUB | DOI | WoS
-
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703F. Oppel, S. Shao, S. Gendreizig, M. W. Zimmerman, M. Schürmann, F. Viyof Ful, P. Goon, S. N. Chi, J. C. Aster, H. Sudhoff, et al., “p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition”, Molecular Cancer Therapeutics, 2022.PUB | DOI | WoS | PubMed | Europe PMC
-
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2951607F. Oppel, M. Görner, and H. Sudhoff, “The Potential of Tumor Debulking to Support Molecular Targeted Therapies”, Frontiers in Oncology, 2020, 10, : 801.PUB | DOI | WoS | PubMed | Europe PMC